Who Are We?
The Quantitative MR Imaging and Spectroscopy Group (QMISG) is dedicated to advancing magnetic resonance quantification through a multidisciplinary team of researchers and physicians. We focus on innovative imaging technologies for accurate disease diagnoses and monitoring. Key projects include cortical bone quality assessment, brain tumor contouring, prostate cancer screening, and Alzheimer’s classification. Our research services encompass whole-body MR imaging, MRS signal analysis, and fMRI analysis. By enhancing imaging capabilities, we aim to improve disease characterization and patient outcomes, supporting clinicians and researchers.
INTERNATIONAL CORPORATION
At QMISG, we believe that the future of MRI/S will be premised on formation of advance imaging and quantification technologies to investigate disease progression biomarkers.
CREATIVE EDUCATION
QMISG embraces an oriented educational and research base community to provide physicians, surgeons, radiologists and patients with excellent services.
INNOVATIVE RESEARCH
QMISG is a multi-disciplinary magnetic resonance quantification research group established in 2012 at the Research Center for Molecular and Cellular Imaging (RCMCI).
Diffusion MRI for Assessment of Bone Quality; A Review of Findings in Healthy Aging and Osteoporosis
